Analysis of the Use of Digoxin Immune Fab for the Treatment of Non-Life-Threatening Digoxin Toxicity

@article{Didomenico2000AnalysisOT,
  title={Analysis of the Use of Digoxin Immune Fab for the Treatment of Non-Life-Threatening Digoxin Toxicity},
  author={R. Didomenico and S. M. Walton and C. Sanoski and J. Bauman},
  journal={Journal of Cardiovascular Pharmacology and Therapeutics},
  year={2000},
  volume={5},
  pages={77 - 85}
}
Background: Studies indicate that digoxin toxicity often results in lengthy hospitalizations and considerable costs, both of which may be decreased through the routine use of digoxin immune Fab (FAB). Methods: A computer-based decision analysis model was developed to compare the treat ment of non-life-threatening digoxin toxicity with either FAB or standard therapy from the hospital perspective. A cost-minimization analysis was then performed to compare overall total costs (primary endpoint… Expand
Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4)
Mechanisms, Manifestations, and Management of Digoxin Toxicity in the Modern Era
Digoxin-Specific Antibody Fragments
Fab Antibody Fragments
Digoxin: current use and approach to toxicity.
Editorial: Antidotes and rescue therapies.
...
1
2
...

References

SHOWING 1-10 OF 22 REFERENCES
Disposition of digoxin immune fab in patients with kidney failure
Digoxin toxicity: an evaluation in current clinical practice.
...
1
2
3
...